{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:15:53Z","timestamp":1769969753673,"version":"3.49.0"},"reference-count":45,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T00:00:00Z","timestamp":1622332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA193815"],"award-info":[{"award-number":["CA193815"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Bladder cancer is one of the most common cancers in the world. Early stage bladder tumors can be surgically removed, but these patients usually have relapses. When bladder cancer becomes metastatic, survival is very low. There is an urgent need for new treatments for metastatic bladder cancers. Here, we report that a new fascin inhibitor decreases the migration and adhesion of bladder cancer cells. Furthermore, this inhibitor decreases the primary tumor growth and increases the overall survival of mice bearing bladder cancers, alone, as well as in combination with the chemotherapy medication, cisplatin, or the immune checkpoint inhibitor, anti-PD-1 antibody. These data suggest that fascin inhibitors can be explored as a new treatment for bladder cancers.<\/jats:p>","DOI":"10.3390\/cancers13112698","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:22:15Z","timestamp":1622420535000},"page":"2698","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fascin Inhibitors Decrease Cell Migration and Adhesion While Increase Overall Survival of Mice Bearing Bladder Cancers"],"prefix":"10.3390","volume":"13","author":[{"given":"Zhankui","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Jillian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Novita Pharmaceuticals, Inc., New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA"},{"name":"Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrurol.2011.144","article-title":"Urothelial carcinoma of the bladder: Definition, treatment and future efforts","volume":"8","author":"Prasad","year":"2011","journal-title":"Nat. Rev. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer Statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrurol.2017.199","article-title":"Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockade","volume":"15","author":"Galsky","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","article-title":"Molecular and histopathology directed therapy for advanced bladder cancer","volume":"16","author":"Alifrangis","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrurol.2017.190","article-title":"Immunotherapy in metastatic urothelial carcinoma: Focus on immune checkpoint inhibition","volume":"15","author":"Curti","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1146\/annurev.cellbio.21.122303.120306","article-title":"The great escape: When cancer cells hijack the genes for chemotaxis and motility","volume":"21","author":"Condeelis","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1175862","article-title":"Actin, a central player in cell shape and movement","volume":"326","author":"Pollard","year":"2009","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm2406","article-title":"Filopodia: Molecular architecture and cellular functions","volume":"9","author":"Mattila","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_9","first-page":"507","article-title":"Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity","volume":"4","author":"Coopman","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1529\/biophysj.104.056515","article-title":"The physics of filopodial protrusion","volume":"89","author":"Mogilner","year":"2005","journal-title":"Biophys. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0092-8674(79)90154-5","article-title":"Formation of filopodia in coelomocytes: Localization of fascin, a 58,000 dalton actin cross-linking protein","volume":"17","author":"Otto","year":"1979","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0022-2836(78)90345-5","article-title":"Separation and interaction of the major components of sea urchin actin gel","volume":"125","author":"Bryan","year":"1978","journal-title":"J. Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/S0021-9258(18)89183-9","article-title":"Purification and characterization of an F-actin-bundling 55-kilodalton protein from HeLa cells","volume":"260","author":"Matsumura","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1083\/jcb.200208059","article-title":"Formation of filopodia-like bundles in vitro from a dendritic network","volume":"160","author":"Vignjevic","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1083\/jcb.200603013","article-title":"Role of fascin in filopodial protrusion","volume":"174","author":"Vignjevic","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/febs.15484","article-title":"How does fascin promote cancer metastasis?","volume":"288","author":"Lin","year":"2021","journal-title":"FEBS J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/1078-0432.CCR-08-1789","article-title":"Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer","volume":"15","author":"Darnel","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0169-5002(03)00294-0","article-title":"Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids","volume":"42","author":"Pelosi","year":"2003","journal-title":"Lung Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000081327","article-title":"The prognostic relevance of fascin expression in human gastric carcinoma","volume":"67","author":"Hashimoto","year":"2004","journal-title":"Oncology"},{"key":"ref_20","first-page":"67","article-title":"Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary","volume":"24","author":"Cao","year":"2005","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-05-2281","article-title":"Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas","volume":"12","author":"Sarrio","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00109-020-01877-z","article-title":"Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells","volume":"98","author":"Rodrigues","year":"2020","journal-title":"J. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Alburquerque-Gonzalez, B., Bernabe-Garcia, A., Bernabe-Garcia, M., Ruiz-Sanz, J., Lopez-Calderon, F.F., Gonnelli, L., Banci, L., Pena-Garcia, J., Luque, I., and Nicolas, F.J. (2021). The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo. Cancers, 13.","DOI":"10.3390\/cancers13040861"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/cib.3.3.11556","article-title":"Fascin: Invasive filopodia promoting metastasis","volume":"3","author":"Machesky","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Tan, V.Y., Lewis, S.J., Adams, J.C., and Martin, R.M. (2013). Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: A systematic review and meta-analysis. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-52"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1054\/bjoc.2000.1395","article-title":"Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer","volume":"83","author":"Grothey","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.biocel.2005.05.004","article-title":"Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker?","volume":"37","author":"Hashimoto","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cm.20356","article-title":"Fascin1 is dispensable for mouse development but is favorable for neonatal survival","volume":"66","author":"Yamakita","year":"2009","journal-title":"Cell Motil. Cytoskelet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1053\/j.gastro.2014.01.046","article-title":"Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejcb.2014.08.002","article-title":"Conditional expression of fascin increases tumor progression in a mouse model of intestinal cancer","volume":"93","author":"Schoumacher","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1038\/ncomms8465","article-title":"Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization","volume":"6","author":"Huang","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.molonc.2016.03.006","article-title":"Improving fascin inhibitors to block tumor cell migration and metastasis","volume":"10","author":"Han","year":"2016","journal-title":"Mol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jmb.2018.03.009","article-title":"Structural Insights into the Induced-fit Inhibition of Fascin by a Small-Molecule Inhibitor","volume":"430","author":"Huang","year":"2018","journal-title":"J. Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/onc.2016.172","article-title":"Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response","volume":"36","author":"Nickerson","year":"2017","journal-title":"Oncogene"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, J.J., and Huang, X.Y. (2020). Anti-Metastasis Fascin Inhibitors Decrease the Growth of Specific Subtypes of Cancers. Cancers, 12.","DOI":"10.3390\/cancers12082287"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"108948","DOI":"10.1016\/j.celrep.2021.108948","article-title":"Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity","volume":"35","author":"Wang","year":"2021","journal-title":"Cell Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: The first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.seminoncol.2006.12.008","article-title":"Chemotherapy for metastatic or unresectable bladder cancer","volume":"34","author":"Bellmunt","year":"2007","journal-title":"Semin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1074\/jbc.M112.427971","article-title":"Molecular Mechanism of Fascin Function in Filopodial Formation","volume":"288","author":"Yang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.cub.2014.05.023","article-title":"Fascin plays a role in stress fiber organization and focal adhesion disassembly","volume":"24","author":"Elkhatib","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_41","first-page":"1017","article-title":"Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro","volume":"62","author":"Summerhayes","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11774","DOI":"10.1073\/pnas.1410626111","article-title":"Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells","volume":"111","author":"Kim","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.celrep.2019.08.011","article-title":"Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments","volume":"28","author":"Lin","year":"2019","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-gamma and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1172\/JCI71812","article-title":"DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis","volume":"124","author":"Wang","year":"2014","journal-title":"J. Clin. Investig."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/11\/2698\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:09:03Z","timestamp":1760162943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/11\/2698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,30]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["cancers13112698"],"URL":"https:\/\/doi.org\/10.3390\/cancers13112698","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,30]]}}}